279 related articles for article (PubMed ID: 11745682)
21. Lymphatic endothelium: a new frontier of metastasis research.
Karkkainen MJ; Mäkinen T; Alitalo K
Nat Cell Biol; 2002 Jan; 4(1):E2-5. PubMed ID: 11780131
[TBL] [Abstract][Full Text] [Related]
22. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
[TBL] [Abstract][Full Text] [Related]
23. Lymphangiogenesis by blind-ended vessel sprouting is concurrent with hemangiogenesis by vascular splitting.
Parsons-Wingerter P; McKay TL; Leontiev D; Vickerman MB; Condrich TK; Dicorleto PE
Anat Rec A Discov Mol Cell Evol Biol; 2006 Mar; 288(3):233-47. PubMed ID: 16489601
[TBL] [Abstract][Full Text] [Related]
24. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
Lohela M; Bry M; Tammela T; Alitalo K
Curr Opin Cell Biol; 2009 Apr; 21(2):154-65. PubMed ID: 19230644
[TBL] [Abstract][Full Text] [Related]
25. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
[TBL] [Abstract][Full Text] [Related]
27. [Receptors for factors of the VEGF (Vascular Endothelial Growth Family)].
Fournier E; Birnbaum D; Borg JP
Bull Cancer; 1997 Apr; 84(4):397-405. PubMed ID: 9238164
[TBL] [Abstract][Full Text] [Related]
28. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.
Valtola R; Salven P; Heikkilä P; Taipale J; Joensuu H; Rehn M; Pihlajaniemi T; Weich H; deWaal R; Alitalo K
Am J Pathol; 1999 May; 154(5):1381-90. PubMed ID: 10329591
[TBL] [Abstract][Full Text] [Related]
29. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B
Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256
[TBL] [Abstract][Full Text] [Related]
30. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
[TBL] [Abstract][Full Text] [Related]
31. Interaction of rat tumor cells with blood vessels and lymphatics of the avian chorioallantoic membrane.
Papoutsi M; Sleeman JP; Wilting J
Microsc Res Tech; 2001 Oct; 55(2):100-7. PubMed ID: 11596155
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
[TBL] [Abstract][Full Text] [Related]
33. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
34. Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma.
Witte D; Thomas A; Ali N; Carlson N; Younes M
Anticancer Res; 2002; 22(3):1463-6. PubMed ID: 12168824
[TBL] [Abstract][Full Text] [Related]
35. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
36. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
Vajkoczy P; Farhadi M; Gaumann A; Heidenreich R; Erber R; Wunder A; Tonn JC; Menger MD; Breier G
J Clin Invest; 2002 Mar; 109(6):777-85. PubMed ID: 11901186
[TBL] [Abstract][Full Text] [Related]
37. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
Partanen TA; Alitalo K; Miettinen M
Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
[TBL] [Abstract][Full Text] [Related]
38. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues.
Partanen TA; Arola J; Saaristo A; Jussila L; Ora A; Miettinen M; Stacker SA; Achen MG; Alitalo K
FASEB J; 2000 Oct; 14(13):2087-96. PubMed ID: 11023993
[TBL] [Abstract][Full Text] [Related]
39. The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed during the remodeling of free tendon grafts in sheep.
Petersen W; Unterhauser F; Pufe T; Zantop T; Südkamp NP; Weiler A
Arch Orthop Trauma Surg; 2003 May; 123(4):168-74. PubMed ID: 12734715
[TBL] [Abstract][Full Text] [Related]
40. Biology of vascular endothelial growth factors.
Roy H; Bhardwaj S; Ylä-Herttuala S
FEBS Lett; 2006 May; 580(12):2879-87. PubMed ID: 16631753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]